Contact
searchSearch
HMP Global

Obesity Topic Center

Featured Article

News
Long-Term Study Reveals Sustained Metabolic Adaptation After Gastric Bypass Surgery
10/21/2024
A study published in the International Journal of Obesity found that gastric bypass surgery leads to significant long-term weight loss and metabolic changes, suggesting that maintaining fat-free mass may help sustain metabolic rates...
A study published in the International Journal of Obesity found that gastric bypass surgery leads to significant long-term weight loss and metabolic changes, suggesting that maintaining fat-free mass may help sustain metabolic rates...
A study published in the...
10/21/2024
First Report Managed Care
News
Helicobacter pylori May Hinder Efficacy of Sleeve Gastrectomy in Patients With Diabetes
10/08/2024
Helicobacter pylori infection may curb the benefit of sleeve gastrectomy in patients with obesity and diabetes, according to a study published in the International Journal of Obesity.
Helicobacter pylori infection may curb the benefit of sleeve gastrectomy in patients with obesity and diabetes, according to a study published in the International Journal of Obesity.
Helicobacter pylori infection...
10/08/2024
First Report Managed Care
News
Obesity Significantly Increases Cancer Risk in Patients With Cardiovascular Disease
09/16/2024
Obesity is associated with an increased cancer risk in patients with cardiovascular disease (CVD), highlighting the need for targeted prevention strategies, according to study results published in the Journal of the American Heart...
Obesity is associated with an increased cancer risk in patients with cardiovascular disease (CVD), highlighting the need for targeted prevention strategies, according to study results published in the Journal of the American Heart...
Obesity is associated with an...
09/16/2024
First Report Managed Care
News
Obesity's Dual Role in Abdominal Aortic Aneurysm: Risk Factor and Protective Paradox
09/03/2024
Obesity, traditionally recognized as a significant public health threat due to its association with numerous metabolic, inflammatory, and psychosocial conditions, is now emerging as a complex factor in the development and progression of...
Obesity, traditionally recognized as a significant public health threat due to its association with numerous metabolic, inflammatory, and psychosocial conditions, is now emerging as a complex factor in the development and progression of...
Obesity, traditionally...
09/03/2024
First Report Managed Care
News
Dietary Patterns May Reshape Microbiota to Combat Obesity
08/19/2024
Dietary patterns that promote beneficial gut microbiota show promise in combating obesity and related metabolic diseases, according to recent research published in Frontiers in Nutrition.
Dietary patterns that promote beneficial gut microbiota show promise in combating obesity and related metabolic diseases, according to recent research published in Frontiers in Nutrition.
Dietary patterns that promote...
08/19/2024
First Report Managed Care
News
Obesity Linked to Distinct Heart Muscle Abnormalities in Patients With HFpEF, Study Finds
08/05/2024
A recent study published in Nature Cardiovascular Research highlighted the significant impact of severe obesity on myocardial ultrastructure in patients with heart failure with preserved ejection fraction (HFpEF), revealing potential...
A recent study published in Nature Cardiovascular Research highlighted the significant impact of severe obesity on myocardial ultrastructure in patients with heart failure with preserved ejection fraction (HFpEF), revealing potential...
A recent study published in...
08/05/2024
First Report Managed Care
News
Few Medicare Providers Offer Intensive Behavioral Therapy for Obesity
10/23/2023
Just 1% of primary care providers who cared for Medicare beneficiaries provided intensive behavioral therapy (IBT) for obesity at any time between 2013 and 2019, according to a study published online in PLOS One.
Just 1% of primary care providers who cared for Medicare beneficiaries provided intensive behavioral therapy (IBT) for obesity at any time between 2013 and 2019, according to a study published online in PLOS One.
Just 1% of primary care...
10/23/2023
First Report Managed Care
News
Obesity Drug Comparison Ranks Semaglutide Tops for Weight Loss, Waist Reduction
06/27/2023
Semaglutide and phentermine/topiramate were associated with more weight loss and waist circumference reduction at 12 months compared with other obesity drugs, according to results from a systematic review and network meta-analysis. 
Semaglutide and phentermine/topiramate were associated with more weight loss and waist circumference reduction at 12 months compared with other obesity drugs, according to results from a systematic review and network meta-analysis. 
Semaglutide and...
06/27/2023
First Report Managed Care
News
BMI Improvement With Liraglutide Possible in Teens Regardless of Baseline Traits
06/23/2023
“These results suggest that liraglutide may be a relevant treatment option for adolescents with obesity with an insufficient response to lifestyle therapy, irrespective of baseline characteristics,” wrote corresponding author Megan O...
“These results suggest that liraglutide may be a relevant treatment option for adolescents with obesity with an insufficient response to lifestyle therapy, irrespective of baseline characteristics,” wrote corresponding author Megan O...
“These results suggest that...
06/23/2023
First Report Managed Care
News
Subcutaneous Therapy Boosts Health-Related Quality of Life in Patients With Overweight, Obesity
05/25/2023
Using data from four phase 3 clinical trials, researchers analyzed the impact of subcutaneous semaglutide, administered once weekly, on participants' health-related quality of life. 
Using data from four phase 3 clinical trials, researchers analyzed the impact of subcutaneous semaglutide, administered once weekly, on participants' health-related quality of life. 
Using data from four phase 3...
05/25/2023
First Report Managed Care
News
Study Finds Single-Anastomosis Sleeve Ileal Bypass Surgery Is Safe, Effective
05/23/2023
According to study authors, “SASI bypass appears to be safe, and one of the most effective bariatric procedures regarding weight loss and obesity related comorbidities.”
According to study authors, “SASI bypass appears to be safe, and one of the most effective bariatric procedures regarding weight loss and obesity related comorbidities.”
According to study authors,...
05/23/2023
First Report Managed Care

Newsfeed

News
Long-Term Study Reveals Sustained Metabolic Adaptation After Gastric Bypass Surgery
10/21/2024
A study published in the International Journal of Obesity found that gastric bypass surgery leads to significant long-term weight loss and metabolic changes, suggesting that maintaining fat-free mass may help sustain metabolic rates...
A study published in the International Journal of Obesity found that gastric bypass surgery leads to significant long-term weight loss and metabolic changes, suggesting that maintaining fat-free mass may help sustain metabolic rates...
A study published in the...
10/21/2024
First Report Managed Care
News
Helicobacter pylori May Hinder Efficacy of Sleeve Gastrectomy in Patients With Diabetes
10/08/2024
Helicobacter pylori infection may curb the benefit of sleeve gastrectomy in patients with obesity and diabetes, according to a study published in the International Journal of Obesity.
Helicobacter pylori infection may curb the benefit of sleeve gastrectomy in patients with obesity and diabetes, according to a study published in the International Journal of Obesity.
Helicobacter pylori infection...
10/08/2024
First Report Managed Care
News
Obesity Significantly Increases Cancer Risk in Patients With Cardiovascular Disease
09/16/2024
Obesity is associated with an increased cancer risk in patients with cardiovascular disease (CVD), highlighting the need for targeted prevention strategies, according to study results published in the Journal of the American Heart...
Obesity is associated with an increased cancer risk in patients with cardiovascular disease (CVD), highlighting the need for targeted prevention strategies, according to study results published in the Journal of the American Heart...
Obesity is associated with an...
09/16/2024
First Report Managed Care
News
Obesity's Dual Role in Abdominal Aortic Aneurysm: Risk Factor and Protective Paradox
09/03/2024
Obesity, traditionally recognized as a significant public health threat due to its association with numerous metabolic, inflammatory, and psychosocial conditions, is now emerging as a complex factor in the development and progression of...
Obesity, traditionally recognized as a significant public health threat due to its association with numerous metabolic, inflammatory, and psychosocial conditions, is now emerging as a complex factor in the development and progression of...
Obesity, traditionally...
09/03/2024
First Report Managed Care
News
Dietary Patterns May Reshape Microbiota to Combat Obesity
08/19/2024
Dietary patterns that promote beneficial gut microbiota show promise in combating obesity and related metabolic diseases, according to recent research published in Frontiers in Nutrition.
Dietary patterns that promote beneficial gut microbiota show promise in combating obesity and related metabolic diseases, according to recent research published in Frontiers in Nutrition.
Dietary patterns that promote...
08/19/2024
First Report Managed Care
News
Obesity Linked to Distinct Heart Muscle Abnormalities in Patients With HFpEF, Study Finds
08/05/2024
A recent study published in Nature Cardiovascular Research highlighted the significant impact of severe obesity on myocardial ultrastructure in patients with heart failure with preserved ejection fraction (HFpEF), revealing potential...
A recent study published in Nature Cardiovascular Research highlighted the significant impact of severe obesity on myocardial ultrastructure in patients with heart failure with preserved ejection fraction (HFpEF), revealing potential...
A recent study published in...
08/05/2024
First Report Managed Care
News
Few Medicare Providers Offer Intensive Behavioral Therapy for Obesity
10/23/2023
Just 1% of primary care providers who cared for Medicare beneficiaries provided intensive behavioral therapy (IBT) for obesity at any time between 2013 and 2019, according to a study published online in PLOS One.
Just 1% of primary care providers who cared for Medicare beneficiaries provided intensive behavioral therapy (IBT) for obesity at any time between 2013 and 2019, according to a study published online in PLOS One.
Just 1% of primary care...
10/23/2023
First Report Managed Care
News
Obesity Drug Comparison Ranks Semaglutide Tops for Weight Loss, Waist Reduction
06/27/2023
Semaglutide and phentermine/topiramate were associated with more weight loss and waist circumference reduction at 12 months compared with other obesity drugs, according to results from a systematic review and network meta-analysis. 
Semaglutide and phentermine/topiramate were associated with more weight loss and waist circumference reduction at 12 months compared with other obesity drugs, according to results from a systematic review and network meta-analysis. 
Semaglutide and...
06/27/2023
First Report Managed Care
News
BMI Improvement With Liraglutide Possible in Teens Regardless of Baseline Traits
06/23/2023
“These results suggest that liraglutide may be a relevant treatment option for adolescents with obesity with an insufficient response to lifestyle therapy, irrespective of baseline characteristics,” wrote corresponding author Megan O...
“These results suggest that liraglutide may be a relevant treatment option for adolescents with obesity with an insufficient response to lifestyle therapy, irrespective of baseline characteristics,” wrote corresponding author Megan O...
“These results suggest that...
06/23/2023
First Report Managed Care
News
Subcutaneous Therapy Boosts Health-Related Quality of Life in Patients With Overweight, Obesity
05/25/2023
Using data from four phase 3 clinical trials, researchers analyzed the impact of subcutaneous semaglutide, administered once weekly, on participants' health-related quality of life. 
Using data from four phase 3 clinical trials, researchers analyzed the impact of subcutaneous semaglutide, administered once weekly, on participants' health-related quality of life. 
Using data from four phase 3...
05/25/2023
First Report Managed Care
News
Using Deep Learning to Measure MS-Specific Brain Damage Beyond Aging
11/11/2024
A new study published in Neurology aimed to differentiate age-related brain changes from multiple sclerosis (MS)-specific neurodegeneration using MRI.
A new study published in Neurology aimed to differentiate age-related brain changes from multiple sclerosis (MS)-specific neurodegeneration using MRI.
A new study published in...
11/11/2024
First Report Managed Care
News
Adverse Event Data Suggest Selective β1-blockers Pose Asthma Risk
11/11/2024
The risks of asthma and asthma-like adverse events appear to be higher with selective β1-blockers than with nonselective blockers and α- and β-blockers.
The risks of asthma and asthma-like adverse events appear to be higher with selective β1-blockers than with nonselective blockers and α- and β-blockers.
The risks of asthma and...
11/11/2024
First Report Managed Care
News
RNAi Therapies Offer New Hope for Patients With Hereditary Transthyretin Amyloidosis
11/08/2024
RNA interference (RNAi)-based treatments for hereditary transthyretin amyloidosis (ATTR) have shown remarkable promise, offering new hope for patients with this rare but devastating genetic disorder.
RNA interference (RNAi)-based treatments for hereditary transthyretin amyloidosis (ATTR) have shown remarkable promise, offering new hope for patients with this rare but devastating genetic disorder.
RNA interference (RNAi)-based...
11/08/2024
First Report Managed Care
News
Revolutionary Single-Dose Gene Therapy Offers New Hope for Adults with Hemophilia B
11/08/2024
A groundbreaking gene therapy for hemophilia B has shown remarkable success in reducing bleeding episodes and improving the quality of life for adult patients, according to a recent international phase III clinical trial.
A groundbreaking gene therapy for hemophilia B has shown remarkable success in reducing bleeding episodes and improving the quality of life for adult patients, according to a recent international phase III clinical trial.
A groundbreaking gene therapy...
11/08/2024
First Report Managed Care
News
Real-World Evidence Supports Efficacy and Safety of Selexipag in Patients With Pulmonary Arterial Hypertension
11/07/2024
Real-world data shows selexipag effectively improves functional class and risk category outcomes in patients with pulmonary arterial hypertension, regardless of maintenance dose.
Real-world data shows selexipag effectively improves functional class and risk category outcomes in patients with pulmonary arterial hypertension, regardless of maintenance dose.
Real-world data shows selexipag...
11/07/2024
First Report Managed Care
News
Clinical Predictors of One-Year Seizure Freedom After SLAH
11/06/2024
A study published in Annals of Clinical and Translational Neurology aimed to predict 1-year seizure freedom for patients undergoing stereotactic laser amygdalohippocampotomy (SLAH) for mesial temporal lobe epilepsy (MTLE) using a set of...
A study published in Annals of Clinical and Translational Neurology aimed to predict 1-year seizure freedom for patients undergoing stereotactic laser amygdalohippocampotomy (SLAH) for mesial temporal lobe epilepsy (MTLE) using a set of...
A study published in Annals of...
11/06/2024
First Report Managed Care
News
Efficacy and Outcomes of Neoadjuvant Immunotherapy in Lung Cancer
11/05/2024
A meta-analysis of 43 studies suggests that neoadjuvant chemoimmunotherapy may benefit patients with resectable NSCLC and low tumor PD-L1 levels for event-free survival, showing superior outcomes compared to neoadjuvant chemotherapy.
A meta-analysis of 43 studies suggests that neoadjuvant chemoimmunotherapy may benefit patients with resectable NSCLC and low tumor PD-L1 levels for event-free survival, showing superior outcomes compared to neoadjuvant chemotherapy.
A meta-analysis of 43 studies...
11/05/2024
First Report Managed Care
News
FDA Grants Accelerated Approval for Asciminib as First-Line Treatment in Ph+CML-CP
11/01/2024
Novartis received accelerated approval by the US Food and Drug Administration (FDA) for asciminib, a medication for adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase (Ph+CML-CP).
Novartis received accelerated approval by the US Food and Drug Administration (FDA) for asciminib, a medication for adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase (Ph+CML-CP).
Novartis received accelerated...
11/01/2024
First Report Managed Care
News
HHS Faces Legal Action From 10 Hospitals Over 2023 Medicare Advantage Rule and Reimbursement Calculations
10/30/2024
Ten hospitals sued the US Department of Health and Human Services (HHS), claiming that they were underpaid Medicare reimbursements for serving low-income patients.
Ten hospitals sued the US Department of Health and Human Services (HHS), claiming that they were underpaid Medicare reimbursements for serving low-income patients.
Ten hospitals sued the US...
10/30/2024
First Report Managed Care
News
Impact of Immune Checkpoint Inhibitors on Multiple Sclerosis Treatment Outcomes
10/29/2024
Relapses and progression of multiple sclerosis were rare in patients treated with immune checkpoint inhibitors, according to a study presented at the American Academy of Neurology 2024 Annual Meeting.
Relapses and progression of multiple sclerosis were rare in patients treated with immune checkpoint inhibitors, according to a study presented at the American Academy of Neurology 2024 Annual Meeting.
Relapses and progression of...
10/29/2024
First Report Managed Care
FRMC Volume 21, Issue 3

Current Issue

September 2024
Volume 21
Issue 3
Current Issue
Issue Archive

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use